FIRST LITHIUM LIMITED — Annual Report 2017

Aug 30, 2017

Appendix 4E

Preliminary final report

1. Details of reporting period

1. Details of reporting period
Name of entity	Ookami Limited
ABN	67 009 081 770
ReportingYear	Year ended 30 June 2017
Previous CorrespondingYear	Year ended 30 June 2016

2. Results for announcement to the market

Key information	12 months ended 30 June 2017 $	12 months ended 30 June 2016 $	Increase/ (decrease) %	Amount change $
Revenues from ordinaryactivities	114,307	19,0801	499%	95,227
Profit/(Loss) from ordinary activities after tax attributable to members	(503,335)	9,393,508	(105%)	(9,896,843)
Net Profit/ (Loss) for the period attributable to members	(503,335)	9,393,508	(105%)	(9,896,843)
Net tangible asset/(deficiency) per share	0.011	0.012	-	-

3. Consolidated statement of profit or loss and other comprehensive income

Refer to attached consolidated financial statements.

4. Consolidated statement of financial position

Refer to attached consolidated financial statements.

5. Consolidated statement of cash flows

Refer to attached consolidated financial statements.

6. Consolidated statement of changes in equity

Refer to attached consolidated financial statements.

7. Dividends/Distributions

No dividends declared in current or prior year.

8. Details of dividend reinvestment plans

N/A

1 FY 2016 exclusive of Gain on creditor release.

Page | 1

9. Details of entities over which control has been gained or lost during the period

Refer to attached consolidated financial statements.

10. Details of associate and joint venture entities

N/A

11. Any other significant information needed by an investor to make an informed assessment of the Company’s financial performance and financial position

Refer to attached consolidated financial statements.

12. Foreign entities

Refer to attached consolidated financial statements.

13. Commentary on results for period and explanatory information

Financial Review

The net assets of the Group have decreased from a surplus of $3,660,784 at 30 June 2016 to $3,157,449 at 30 June 2017.

As at 30 June 2017, the Group's cash and cash equivalents decreased from a balance at 30 June 2016 of $3,141,828 to a balance at 30 June 2017 of $2,664,218 and had working capital of $2,588,532 (2016: $3,091,867).

Operational Highlights

• The Company, via Akela, secured an allocation for its members in Cr8tek’s (ASX:CR8) capital raising for CR8’s Flamingo acquisition.

• Secured an allocation for its platform’s subscribers in the Initial Public Offering (IPO) for openDNA Ltd (ASX:OPN).

• Secured an allocation for its platforms subscribers in the IPO for eSense-Lab Ltd (ASX: ESE).

• Completed an allocation for its platform’s subscribers in the IPO for Servtech Global Holdings Ltd (ASX: SVT).

• Secured an allocation for its platform’s subscribers in the IPO for G Medical Innovations Holdings Ltd (ASX: GMV).

• Akela also secured and completed an allocation for its subscribers in the Calidus Resources Ltd (ASX: CAI) capital raising.

Refer to the attached consolidated financial statements for further details

Page | 2

14. Audit

This report is based on accounts which have been audited and the audit report is included in the attached consolidated financial statements.

==> picture [69 x 56] intentionally omitted <==

Non Executive Chairman Faldi Ismail

31 August 2017

Page | 3